NCT00429182View on ClinicalTrials.gov

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Breast CancerMetastatic Breast CarcinomaInvasive Breast Carcinoma
Interventions
DRUG

Carboplatin

Target Area Under the Curve (AUC) of 20, then divided into 4 doses given by vein (IV) days -6, -5, -4, -3 prior to stem cell infusion.

DRUG

Cyclophosphamide

1.5 gm/m\^2 by vein days -6, -5, -4, -3 prior to stem cell infusion.

DRUG

Thiotepa

120 mg/m\^2 by vein days -6, -5, -4, -3 prior to stem cell infusion.

PROCEDURE

Stem Cell Transplant

Stem Cell Transplant on Day 0.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00429182 - Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter